Prospective melanoma registry study in France
Part of Cancer, Skin clinical trials.
This study builds a future-looking database of people with melanoma in France. It collects information from consenting adults, which may help researchers better understand melanoma over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You have melanoma confirmed by pathology/biopsy
- Your situation is covered by the French social security system
- You can and agree to sign the study consent form
- No medical or mental health issue that would prevent you from giving consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry that collects information from people diagnosed with an invasive skin melanoma. It may help researchers understand who gets melanoma and how it’s diagnosed and treated over time.
This trial studies how your immune system “profiles” change while you’re treated with immunotherapy for melanoma. Results may help doctors better understand who benefits from treatment and when.
This study looks at immune cells in your blood to find patterns that might show how well a treatment called anti-PD1 immunotherapy works for melanoma. Your participation could help doctors better understand who benefits from this therapy.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
This is a hospital-based study that builds a clinical and biological database for people treated for rectal cancer at the Montpellier Cancer Institute. It helps researchers organize health information to better understand rectal cancer and improve future care.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.